
anti-TNFα (adalimumab)
11970 anti-CD52 (alemtuzumab) 11971 anti-EGFR (panitumumab) 11972 murine anti-CD3 (muromonab) 11973 anti-Complement C5 (eculizumab) 11974 anti-IgE (omalizumab) 11963 anti-EGFR (cetuximab) 11964 anti-CTLA-4 (ipilimumab) 11965 anti-HER2 domain II (pertuzumab) 11966 anti-CD20 (rituximab) 11967 anti-HER2 domain IV (trastuzumab) 11968 anti-VEGF (bevacizumab)
- Quality Assurance. Produced with rigorous standards to ensure very low endotoxin levels, consistency, and reliability.
- Extensive Range. A broad spectrum of isotype controls tailored to various species and subclasses.
- Expert Guidance. Support from our team in selecting appropriate isotype controls for specific experimental needs.
Product specifications
| Species | Human |
|---|---|
| Isotype | IgG1 |
| Mutation | WT |
| Concentration | 5 mg/mL |
| Formulation | Dulbecco's PBS (pH 7.2-7.4) |
| Purity | 99.7 % SEC, initial release |
Related products
-
anti-Complement C5 (eculizumab)
Humanized IgG2/4 hybrid. H264Q, F296Y, V305L, A326S, P327S, T335A, R351Q, M393V, K405R, Q415E, P441L. 5 mg/mL in Dulbecco’s PBS (pH 7.2-7.4).
225,00 CHF
Place your order
Send us your order, and we will contact you promptly with delivery and payment details.
View Quote items in your quote
